Trials / Unknown
UnknownNCT04903808
Clinical And Cost- Effectiveness of Allium Sativum Oil (Garlic Oil ) Versus Mineral Trioxide Aggregate in Primary Molars Pulpotomy in Group of Egyptian Children : A Randomised Clinical Pilot Study.
Clinical And Cost- Effectiveness of Allium Sativum Oil Versus Mineral Trioxide Aggregate in Primary Molars Pulpotomy in Group of Egyptian Children : A Randomised Clinical Pilot Study.
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 26 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 5 Years – 7 Years
- Healthy volunteers
- Accepted
Summary
Allium Sativum oil is advocated to prove the capability of new natural products in replacing higher cost pharmacological materials, while achieving the same successful clinical and radiographic long-term results.
Detailed description
One of the most challenging subjects in paediatric dentistry is choosing the ideal pulp medication material that has the required properties such as preserving the vitality of the remaining intact pulp and stimulating its repair. This material should prevent pathological root resorption.Clinical and cost effectiveness trials from different countries are useful to determine which medicament should be advocated in which economic setting . Alternative pulpotomy materials clinically effective as MTA but with lower cost should be studied .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Allium Sativum Oil | Garlic oil Captain Company (CAP-PHARM) |
| DRUG | Mineral Tri-Oxide Aggregate | ProRoot MTA, Dentsply |
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2022-10-01
- Completion
- 2022-10-01
- First posted
- 2021-05-27
- Last updated
- 2021-08-25
Source: ClinicalTrials.gov record NCT04903808. Inclusion in this directory is not an endorsement.